| HOME | CURRENT ISSUE | TABLE OF CONTENTS | ARCHIVE | SEARCH | SUBSCRIPTIONS | JOBS | FEEDBACK | HELP |
|
|
|
|||||||||
|
|||||||||||
The Veterinary Record, Vol 138, Issue 1, 7-11
Copyright © 1996 by British Veterinary Association
1 University of Glasgow, Department of Veterinary Pathology, Bearsden, Glasgow G61 1QH
2 École Nationale Vétérinaire de Nantes, Unité de Pathologie Infectieuse, CP3013, 44087 Nantes Cedex 03, France
The efficacy of three feline leukaemia virus (FeLV) vaccines was compared. Kittens were immunised with either a recombinant subunit vaccine, Leucogen, or one of two inactivated virus vaccines, Leukocell 2 or Leucat. On subsequent challenge by intraperitoneal inoculation of FeLV of subgroup A (FeLV-A), only Leucogen gave significant protection. In a second experiment, kittens vaccinated with Leucogen were protected against oronasal challenge with a phenotypic mixture of FeLV of subgroups A, B and C. These results indicate that a recombinant vaccine, containing only the protein moiety of the surface glycoprotein of FeLV-A, can provide better protection than the inactivated virus vaccines tested against challenge with virus of the same subgroup, and can also protect against challenge by all three subgroups of FeLV.
This article has been cited by other articles:
|
|
 |
|
  M. A. Gomes-Keller, E. Gonczi, R. Tandon, F. Riondato, R. Hofmann-Lehmann, M. L. Meli, and H. Lutz Detection of feline leukemia virus RNA in saliva from naturally infected cats and correlation of PCR results with those of current diagnostic methods. J. Clin. Microbiol., March 1, 2006; 44(3): 916 - 922. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. N. Flynn, S. P. Dunham, V. Watson, and O. Jarrett Longitudinal Analysis of Feline Leukemia Virus-Specific Cytotoxic T Lymphocytes: Correlation with Recovery from Infection J. Virol., March 1, 2002; 76(5): 2306 - 2315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Hanlon, D. Argyle, D. Bain, L. Nicolson, S. Dunham, M. C. Golder, M. McDonald, C. McGillivray, O. Jarrett, J. C. Neil, et al. Feline Leukemia Virus DNA Vaccine Efficacy Is Enhanced by Coadministration with Interleukin-12 (IL-12) and IL-18 Expression Vectors J. Virol., September 15, 2001; 75(18): 8424 - 8433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Hofmann-Lehmann, J. B. Huder, S. Gruber, F. Boretti, B. Sigrist, and H. Lutz Feline leukaemia provirus load during the course of experimental infection and in naturally infected cats J. Gen. Virol., July 1, 2001; 82(7): 1589 - 1596. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Baumann, W. H. Gunzburg, and B. Salmons CrFK Feline Kidney Cells Produce an RD114-Like Endogenous Virus That Can Package Murine Leukemia Virus-Based Vectors J. Virol., September 1, 1998; 72(9): 7685 - 7687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. K. Ramsey, N. Spibey, and O. Jarrett The Receptor Binding Site of Feline Leukemia Virus Surface Glycoprotein Is Distinct from the Site Involved in Virus Neutralization J. Virol., April 1, 1998; 72(4): 3268 - 3277. [Abstract] [Full Text] [PDF]
|
|
| HOME | CURRENT ISSUE | TABLE OF CONTENTS | ARCHIVE | SEARCH | SUBSCRIPTIONS | JOBS | FEEDBACK | HELP |
